Biomedical (basic)

Ended Definitive Contract Awarded Last action

Contract number
00261199209D261925514
Awardee
Awarding agency
Obligated
$31,475,538

Award facts

Contract value 6% obligated
  • $552,633,493.37 Current, with exercised options
  • $570,344,932.37 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers
Pricing
Cost No Fee
Place of performance
Aurora, CO 80045, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 90 -$472,792
Other Administrative Action 89 · Prostate, lung, colorectal and ovarian (plco) cancer screening trial - screening center $0
Other Administrative Action 88 $0
Supplemental Agreement for work within scope 87 · Plco pathology collection -- no-cost extension $0
Exercise an Option 86 $1,564,183
Vendor DUNS or Name Change - Non-Novation 85 $0
Supplemental Agreement for work within scope 84 $0
Supplemental Agreement for work within scope 83 $0
Supplemental Agreement for work within scope 82 $646,493
Exercise an Option 81 $46,188
Supplemental Agreement for work within scope 80 $845,536
Other Administrative Action 79 $0
Funding Only Action 78 $634,631
Supplemental Agreement for work within scope 76 $13,805
Funding Only Action 77 $483
Exercise an Option 75 $19,794
Funding Only Action 74 $622,294
Funding Only Action 73 · Prostate, lung, colorectal and ovarian (plco) cancer screening trial - screening centers $780,711
Additional Work (new agreement, FAR part 6 applies) 72 $20,419
Supplemental Agreement for work within scope 71 $338,910
Exercise an Option 70 $44,396
Funding Only Action 68 $581,546
Funding Only Action 69 $826,140
Supplemental Agreement for work within scope 67 $0
Other Administrative Action 66 $0
Funding Only Action 65 $77,619
Supplemental Agreement for work within scope 64 $0
Supplemental Agreement for work within scope 63 $20,729
Funding Only Action 62 $856,506
Funding Only Action 61 $1,237,601
Other Administrative Action 60 $0
Additional Work (new agreement, FAR part 6 applies) 59 $0
Supplemental Agreement for work within scope 58 $79,295
Funding Only Action 57 $843,035
Funding Only Action 56 $1,966,759
Supplemental Agreement for work within scope 55 $93,133
Supplemental Agreement for work within scope 54 $2,094,699
Funding Only Action 52 $944,862
Other Administrative Action 53 $0
Funding Only Action 51 $812,000
Supplemental Agreement for work within scope 50 $0
Supplemental Agreement for work within scope 49 $370,588
Supplemental Agreement for work within scope 48 $2,124,247
Supplemental Agreement for work within scope 47 $1,025,385
Supplemental Agreement for work within scope 46 $551,343
Supplemental Agreement for work within scope 45 $147,000
Supplemental Agreement for work within scope 44 $1,103,000
Supplemental Agreement for work within scope 43 $910,000
Supplemental Agreement for work within scope 42 $1,079,000
Supplemental Agreement for work within scope 41 $1,143,000
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

About this award

Written by GovTribe AI ·

This federal contract award is for a Definitive Contract with a Ceiling Value of $570,344,932.37, awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for "BIOMEDICAL (BASIC)" services and has an Ultimate Completion Date of December 31, 2011. The University of Colorado-Denver is a major public research university that frequently receives federal funding through contracts and grants to support its research, education, and public service missions, particularly in medical and scientific fields. This contract does not appear to have any set-aside designation.

Additionally, the University of Colorado-Denver holds an Indefinite Delivery Contract (IDC) awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), also part of NIH, to serve as a clinical research site for medication development studies on alcohol use disorder treatments. This IDC has a $48 million ceiling value across all awardees and runs through March 2028. The university has received at least one task order under this vehicle to provide core functions and administrative reporting for the clinical trials network.

Quick answers

Who was awarded contract 00261199209D261925514?

00261199209D261925514 was awarded to The Regents Of The University Of Colorado by National Cancer Institute (National Institutes of Health) on September 29, 1992.

How much is contract 00261199209D261925514 worth?

The government has obligated $31,475,538 on 00261199209D261925514. Its current value, with exercised options, is $552,633,493. Its potential value, with all options, is $570,344,932.

Was contract 00261199209D261925514 competed?

The extent of competition for 00261199209D261925514 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login